-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Lidocaine is a Novel Antispasmodic Agent during Colonoscopy
Kazutomo Togashi, Daiki Nemoto, Taka-aki Koshimizu, Alan Kawarai Lefor
Commentary: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Drug to treat form of Gaucher disease gains FDA approval
News and Views: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation